Radiance Therapeutics Co-founder Dr Wendell Lutz awarded ASTRO Gold Medal

Radiance Therapeutics, a company developing a next-generation Beta Ophthalmic Applicator, is delighted to announce that one of its co-founders, Dr Wendell Lutz, PhD, will be honored by the American Society of Radiation Oncology (ASTRO), during the Annual Meeting Awards Ceremony in San Antonio which will take place on October 25, 2022.

Relatively few names are as synonymous with advancements in radiation oncology as Dr Wendell Lutz, a medical physicist, engineer, inventor, and educator whose contributions have advanced the field of radiation oncology. Dr. Lutz’s career spans decades during which the field has seen growth and innovation. Dr Lutz’s contributions have shaped the practice of radiation oncology today. In 1986, Dr. Lutz revolutionized the field of radiation oncology, leading with Dr. Ken Winston the invention of the linear accelerator (LINAC) based stereotactic radiosurgery system.

It soon became apparent that the system significantly improved the outcomes of patients with functional abnormalities and brain tumors and subsequently this therapy was extended more broadly in cancer treatment. The use of minimally invasive LINAC based stereotactic radiosurgery systems is now a mainstay in modern medicine. The true value of Dr. Lutz’s innovation is its impact on patient care: according to the National Cancer Institute (NCI), 50% of cancer patients are treated with radiosurgery. A humanitarian and academic, with the goal of speeding this therapy to patients, Dr. Lutz and Harvard University’s Joint Center for Radiation Therapy placed his invention into the public domain by directly publishing in peer reviewed medical journals. This created fertile ground for the considerable growth of the global stereotactic surgery devices industry.

Dr Wendell Lutz will receive the highest honor from ASTRO, the ASTRO Gold Medal, which is awarded to individuals who have made an enduring impact on the field of radiation oncology through their clinical patient care, research, teaching, mentorship, and service. Joining Dr. Lutz in this revered class of ASTRO Gold Medal recipients will be Tim R. Williams, MD, FASTRO, another great innovator in this field.

Radiance Therapeutics extends heartfelt congratulations to Drs. Lutz and Williams.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.